Tulsi (Ocimum sanctum), also known as holy basil, is a revered herb in Ayurveda and Southeast Asian medicine for its ...

Department of Endocrinology and Metabolism, Affiliated Hospital of Qingdao University, Qingdao 266003, P. R. China Qingdao Key Laboratory of Thyroid, Diseases, Medical Research Center, Qingdao 266555, ...

TNF inhibitors are “generally considered the first-line therapy as they are safe and effective drugs and biosimilars are available which make them accessible.” However, a trial comparing ustekinumab ...

Tumor necrosis factor (TNF)-α inhibitors are associated with an increased risk of fungal infections, according to the findings of a systematic review published in Mycoses. Investigators explored ...

The tumor necrosis factor (TNF) inhibitor certolizumab pegol (Cimzia) appears to significantly increase the survival rate for pregnancies complicated by antiphospholipid syndrome (APS), an ...

inhibitors showed no increased incidence of major adverse cardiovascular events (MACEs) compared with those treated with tumour necrosis factor (TNF) inhibitors or biologic disease-modifying ...

In addition, head-to-head comparisons with other biological agents were necessary to clarify their relative efficacy and safety profiles (Katsanos and Papadakis, 2017), such as IL-17 or TNF inhibitors ...

Results: During the study period, among 1,382,627 patients in the FAERS database who had adverse events linked to TNF-α inhibitors, 9,714 could be attributed to thrombosis-related adverse events. In ...

Led by AbbVie’s Humira, biologic TNF inhibitors transformed the treatment of autoimmune diseases over the past 20 years. However, the biologic modality can cause adverse effects and loss of ...

Image credit: Shutterstock / LCV Sanofi will halt the development of its oral tumour necrosis factor (TNF) inhibitor balinatunfib as a monotherapy after it failed to reach the primary endpoint in a ...